Dermata Therapeutics, Inc. (DRMA)

NASDAQ: DRMA · Delayed Price · USD
0.050 (7.26%)
At close: May 18, 2022 4:00 PM
-0.080 (-10.823%)
After-hours:May 18, 2022 5:42 PM EDT

Total Valuation

DRMA has a market cap or net worth of $6.83 million. The enterprise value is -$3.97 million.

Market Cap6.83M
Enterprise Value-3.97M

Important Dates

The next earnings date is Monday, June 27, 2022, before market open.

Estimated Earnings DateJun 27, 2022
Ex-Dividend Daten/a

Share Statistics

DRMA has 9.23 million shares outstanding. The number of shares has increased by 125.13% in one year.

Shares Outstanding9.23M
Shares Change (YoY)+125.13%
Shares Change (QoQ)-13.62%
Owned by Insiders (%)47.54%
Owned by Institutions (%)11.71%

Valuation Ratios

PE Ration/a
Forward PEn/a
PS Ration/a
PB Ratio0.68
P/FCF Ration/a
PEG Ration/a
Financial Ratio History

Enterprise Valuation

EV / Earningsn/a
EV / Salesn/a
EV / EBITn/a
EV / FCFn/a

Financial Position

Current Ratio7.66
Quick Ratio7.12
Debt / Equity0.00
Debt / EBITDA0.00
Debt / FCF0.00

Financial Efficiency

Return on equity (ROE) is -183.60%, which is considered low.

Return on Equity (ROE)-183.60%
Return on Assets (ROA)-149.00%
Return on Capital (ROIC)n/a
Revenue Per Employeen/a
Profits Per Employee-$1.31M
Employee Count8
Asset Turnovern/a
Inventory Turnovern/a


Income Taxn/a
Effective Tax Raten/a

Stock Price Statistics

Beta (1Y)n/a
Total Price Change-90.57%
50-Day Moving Average1.08
200-Day Moving Average1.93
Average Volume (30 Days)117,940

Short Selling Information

The latest short interest is 38,125, so 0.41% of the outstanding shares have been sold short.

Short Interest38,125
Short % of Shares Out0.41%
Short % of Float0.91%
Short Ratio (days to cover)0.39

Income Statement

Gross Profitn/a
Operating Income-7.86M
Net Income-7.90M
Net Income Common-10.46M
Earnings Per Share (EPS)-$2.43
Full Income Statement

Balance Sheet

The company has $10.80 million in cash and no debt, giving a net cash position of $10.80 million or $1.17 per share.

Cash & Cash Equivalents10.80M
Total Debt0
Net Cash10.80M
Net Cash Per Share$1.17
Book Value10.11M
Book Value Per Share1.10
Working Capital10.11M
Full Balance Sheet

Cash Flow

Operating Cash Flow-5.69M
Capital Expendituresn/a
Free Cash Flow-5.69M
FCF Per Sharen/a
Full Cash Flow Statement


Gross Marginn/a
Operating Marginn/a
Pretax Marginn/a
Profit Marginn/a
EBITDA Marginn/a
EBIT Marginn/a
FCF Marginn/a

Dividends & Yields

DRMA does not appear to pay any dividends at this time.

Dividend Per Sharen/a
Dividend Yieldn/a
Earnings Yield-153.24%
FCF Yield-83.37%
Dividend Growth (YoY)n/a
Payout Ration/a
Buyback Yield-125.13%
Shareholder Yield-125.13%
Dividend Details

Analyst Forecast

The average price target for DRMA is $9.18, which is 1,140.37% higher than the current price. The consensus rating is "Buy".

Price Target$9.18
Price Target Difference1,140.37%
Analyst ConsensusBuy
Analyst Count8
Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Daten/a
Split Typen/a
Split Ration/a